XML 59 R43.htm IDEA: XBRL DOCUMENT v3.21.1
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2020
Nonvested Restricted Shares

December 31,

2020

2019

Weighted-

Weighted-

Average

Average

Grant Date

Grant Date

Fair Value

Fair Value

Shares

(per share)

Shares

(per share)

Nonvested at the beginning of the year

327,345

$

8.49

133,462

$

16.12

Granted

872,494

1.43

293,309

6.75

Vested

(73,111)

8.18

(40,696)

16.89

Forfeited

(277,005)

3.63

(58,730)

11.27

Nonvested at the end of the year

849,723

$

2.86

327,345

$

8.49

Expected to vest

849,723

$

2.86

327,345

$

8.49

Time-Vested Stock Options [Member]  
Valuation Assumptions, Options

Expected

Risk Free

Grant Date

Expected

Dividend

Interest

Fair Value

Grant Year

Grant Date

Expected Life

Volatility

Yield

Rate

Per Award

2019

4/23/2019

6 years

44.87%

0.00%

2.40%

$3.50

2019

1/14/2019

6 years

44.87%

0.00%

2.57%

$3.43

2018

1/12/2018

6 years

44.25%

0.00%

2.42%

$7.57

Option Activity

December 31,

2020

2019

Weighted-

Weighted-

Average

Average

Exercise

Exercise

Options

Price

Options

Price

Outstanding

(per share)

Outstanding

(per share)

Outstanding at the beginning of the year

313,317

$

12.70

208,426

$

21.47

Granted

-

-

255,009

7.43

Exercised

-

-

-

-

Forfeited or expired

(101,956)

14.81

(150,118)

15.93

Outstanding at the end of the year

211,361

$

11.68

313,317

$

12.70

Exercisable at the end of the year

103,458

$

14.93

82,964

$

23.01

Shares Outstanding

Weighted-

Average

Weighted-

Remaining

Average

Contractual

Exercise

Aggregate

Options

Term

Price

Intrinsic

Outstanding

(in years)

(per share)

Value

Options outstanding

211,361

7.0

$

11.68

$

-

Vested or expected to vest

211,361

7.0

$

11.68

$

-

Options exercisable

103,458

6.1

$

14.93

$

-

Stock Appreciation Rights (SARs) [Member]  
Shares Outstanding

Weighted-

Average

Weighted-

Remaining

Average

Contractual

Exercise

Aggregate

SAR

Term

Price

Intrinsic

Outstanding

(in years)

(per share)

Value

SARS outstanding

853,967

9.1

$

1.69

$

619,728

Vested or expected to vest

853,937

9.1

$

1.69

$

619,725

SARS exercisable

-

-

$

-

$

-

Valuation Assumptions

Expected

Risk Free

Expected

Dividend

Interest

Fair Value

Grant Year

Grant Date

Expected Life

Volatility

Yield

Rate

Per Award

2020

1/24/2020

5.1 years

66.33%

0.00%

0.37%

$1.52

2020

3/9/2020

5.2 years

66.06%

0.00%

0.38%

$1.61

2020

9/14/2020

5.7 years

64.76%

0.00%

0.44%

$1.45

2020

11/30/2020

5.9 years

64.06%

0.00%

0.46%

$1.34

SAR Activity

December 31,

2020

Weighted-

Average

Exercise

SAR

Price

Outstanding

(per share)

Outstanding at the beginning of the year

-

$

-

Granted

1,164,464

1.68

Exercised

-

-

Forfeited or expired

(310,497)

1.64

Outstanding at the end of the year

853,967

$

1.69

Exercisable at the end of the year

-

$

-